A detailed history of Los Angeles Capital Management LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 23,433 shares of ARCT stock, worth $387,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,433
Holding current value
$387,347
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$18.08 - $25.38 $423,668 - $594,729
23,433 New
23,433 $543,000
Q2 2023

Aug 03, 2023

SELL
$23.94 - $32.36 $41,895 - $56,630
-1,750 Reduced 14.2%
10,572 $303,000
Q2 2022

Aug 05, 2022

SELL
$12.26 - $31.17 $579,996 - $1.47 Million
-47,308 Reduced 79.34%
12,322 $194,000
Q1 2022

May 06, 2022

BUY
$17.64 - $39.57 $904,455 - $2.03 Million
51,273 Added 613.53%
59,630 $1.61 Million
Q2 2021

Aug 05, 2021

BUY
$25.79 - $42.11 $215,527 - $351,913
8,357 New
8,357 $283,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.